Study design

Retrospective

Study time

2007.1-2016.12

Country

South Korea

Object

1) aged ≥75 years at the time of treatment; 2) a minimum follow-up of 3 years after treatment to achieve survival result; and 3) a non-metastatic disease status as determined by bone scan, and abdominopelvic computerized tomography (CT) prior to treatment commencement.

Inclusion criteria

1) aged ≥75 years at the time of treatment; 2) a minimum follow-up of 3 years after treatment to achieve survival result; and 3) a non-metastatic disease status as determined by bone scan, and abdominopelvic computerized tomography (CT) prior to treatment commencement

Robots remarks

RARP

Sample size

1110

Topic classification

Focus on RARP，Local Experience，Special populations

Keypoint

Even aged over 75 years, patients who underwent RARP for non-metastatic PCa had similar survival with RT regardless of risk stratification.

Year